High Tower Advisors, LLC Precision Biosciences Inc Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.97 - $45.0 $17,363 - $805,500	-17,900 Reduced 28.69%	44,500 $52,000
Q3 2022 Nov 09, 2022	BUY	$1.22 - $40.8 $28,670 - $958,799	23,500 Added 60.41%	62,400 $81,000
Q2 2022 Aug 10, 2022	BUY	$1.15 - $3.34 $27,254 - $79,158	23,700 Added 155.92%	38,900 $63,000
Q1 2022 May 12, 2022	BUY	$2.96 - $7.76 $44,992 - $117,952	15,200 New	15,200 $47,000
Q4 2021 Feb 10, 2022	SELL	$7.4 - $11.66 $305,168 - $480,846	-41,239 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.18 - $14.15 $378,574 - $583,531	41,239 New	41,239 $476,000
Q4 2020 Feb 10, 2021	SELL	$5.98 - $12.47 $110,032 - $229,448	-18,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.65 - $8.73 $31,201 - $58,578	6,710 Added 57.4%	18,400 $113,000
Q2 2020 Aug 10, 2020	BUY	$4.66 - $8.7 $54,475 - $101,702	11,690 New	11,690 $97,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.